Indian drug companies start off a price war on experimental Covid-19 drug

Over the next few weeks, close to 10 drug companies including Abbott,
Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr
Reddy's Laboratories are expected to launch their own brands of
favipiravir, despite inconclusive evidence of its effectiveness.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-drug-companies-start-off-a-price-war-on-experimental-covid-19-drug/articleshow/77156304.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation